Janumet

✅ Manages blood sugar levels
✅ Reduces the risk of hyperglycemia
✅ Supports diabetes management
✅ Convenient once-daily dosing
✅ Improves overall glycemic control

Janumet contains Sitagliptin and Metformin

Janumet mg/500 mg Tablet is a combination medication used to manage high blood sugar levels in patients with type 2 diabetes. This treatment helps prevent serious diabetes complications like kidney impairment and vision loss, while potentially reducing risks of heart attack and stroke.

Janumet mg/500 mg Tablet can be prescribed as monotherapy or alongside other antidiabetic medications. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is determined by your medical condition, glucose levels, and concurrent medications. Taking it with meals minimizes gastrointestinal discomfort.

For maximum effectiveness, maintain consistent daily dosing times and continue treatment unless advised otherwise by your physician. Adherence to your doctor’s recommended diet and exercise regimen is crucial during therapy, as lifestyle factors significantly impact diabetes management.

Common adverse effects may include diarrhea, nausea, vomiting, abdominal discomfort, headaches, and throat irritation. Concurrent use with insulin or sulfonylureas may increase hypoglycemia risk – patients should learn to recognize and manage low blood sugar symptoms.

This medication isn’t appropriate for all individuals. Inform your healthcare provider about any history of renal, hepatic, or cardiac conditions, pancreatic disorders, or excessive alcohol consumption. Pregnant or nursing women should seek medical advice before use. Disclose all current medications to assess potential interactions. Alcohol consumption should be minimized as it can lower blood glucose. Regular kidney function and blood sugar monitoring will be conducted throughout treatment.

THERAPEUTIC INDICATIONS

  • Management of type 2 diabetes mellitus

CLINICAL BENEFITS

For Type 2 Diabetes Management

Janumet mg/500 mg Tablet contains two active components that synergistically regulate blood glucose through complementary mechanisms. Effective glycemic control is fundamental to diabetes care, as it reduces risks of severe complications including nephropathy, retinopathy, neuropathy, and extremity amputations. Furthermore, optimal diabetes management decreases cardiovascular event risks. Consistent medication use alongside proper nutrition and physical activity promotes long-term health maintenance. Continued adherence to prescribed therapy is essential for protecting against diabetes-related health deterioration.

ADVERSE EFFECTS

Most reactions are transient and resolve with continued therapy. Consult your healthcare provider if symptoms persist or cause concern.

Frequently Reported Reactions

  • Gastrointestinal disturbances (diarrhea, nausea, vomiting)
  • Abdominal discomfort
  • Cephalalgia (headache)
  • Nasal obstruction
  • Pharyngeal irritation
  • Upper respiratory infections
  • Increased hypoglycemia risk when combined with insulin or sulfonylureas

ADMINISTRATION GUIDELINES

Administer exactly as prescribed. Swallow tablets whole with water during meals. Do not crush, chew, or break the tablet.

PHARMACOLOGICAL ACTION

Janumet mg/500 mg Tablet combines Sitagliptin (a DPP-4 inhibitor) and Metformin (a biguanide) to enhance pancreatic insulin secretion, improve insulin sensitivity, and suppress hepatic glucose production, resulting in comprehensive glycemic control.

Disclaimer:

This information is provided for educational purposes only and represents expert-reviewed, evidence-based data. It should not replace professional medical advice, diagnosis, or treatment. The content may not encompass all potential adverse effects, contraindications, or drug interactions. Always consult your healthcare provider regarding any medical condition or treatment options. This resource aims to facilitate informed patient-provider discussions, not to substitute clinical judgment.
Strength

50 + 500 mg, 50 + 1000 mg

Quantity

28 Tablet/s, 56 Tablet/s, 84 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Merck & Co

Treatment

Type 2 diabetes

Reviews

There are no reviews yet

Add a review
Janumet Janumet
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot